Thursday, November 12, 2026

USD/EUR Falls By 2% In The Last 10 Sessions

ViaNews Editorial Team

November 16, 2023

USD/EUR Falls By 2% In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.41% for the last 10 sessions. At 17:06 EST on Thursday, 16 November, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.924% up from its 52-week low and 5.737% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.39%, a negative 0.15%, and a positive 0.31%, respectively.

USD/EUR's highest amplitude of average volatility was 0.59% (last week), 0.36% (last month), and 0.31% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy extends losses below the 20-day sma, eyes on Japanese GDP and US PPI. According to FXStreet on Tuesday, 14 November, "The USD/JPY suffered significant setbacks in Tuesday's session, falling towards the trajectory of the pair being set by soft CPI data from the US. ", "The USD/JPY displays a neutral to bearish technical bias on the daily chart, with signals suggesting that the bears are gaining ground. "
  • Usd/jpy: US CPI data will be crucial to see a break of 33-year high at 151.95 – MUFG. According to FXStreet on Tuesday, 14 November, "The US CPI data will be crucial on whether USD/JPY breaks back higher and through the high from Monday and through the current cyclical high recorded in last year at 151.95, a 33-year high.", "Any Dollar strength will likely be most prevalent in USD/JPY if option-related resistance at 152.00 gives way."
  • Usd/jpy signal: rise against the yen - 14 November 2023. According to DailyForex on Tuesday, 14 November, " Potential signal: If the USD/JPY CLOSES above 152 for the session, I am buying here. "
  • Usd/jpy hovers around 151.70, US CPI data looms. According to FXStreet on Tuesday, 14 November, "The USD/JPY pair consolidates its recent losses during the Asian session on Tuesday. ", "This, in turn, might lift the US Dollar (USD) and act as a tailwind for the USD/JPY pair. "
  • Usd/jpy technical analysis: amid stability around the highest level in A year - 14 November 2023. According to DailyForex on Tuesday, 14 November, "Therefore, if an event occurs that will change the trend of the USD/JPY currency pair to a strong bearish direction in a very short time, wherever, we do not prefer to buy with a risk from those peaks. ", "In this regard, Valentin Marinov, Forex analyst at Credit Agricole, says, "The overvaluation of the USD/JPY pair has increased to approximately two standard deviations. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com